Inge P. Salzmann

Inge P. Salzmann

Auto-generated profile, based on publicly available information

Inge P. Salzmann

Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2023 in IEEE Transactions on Instrumentation and Measurement
Verified
Journal Article
Closed access
EFEnrico Ferlinghetti
Enrico Ferlinghetti
ISInge Salzmann
Inge Salzmann
Marco GhidelliMarco Ghidelli
Marco Ghidelli
TRThomas Rietveld
Thomas Rietveld
Riemer JK VegterRiemer JK Vegter
Riemer JK Vegter
Matteo LANCINIMatteo LANCINI
Matteo LANCINI
This study investigates the reliability of marker-less vision systems for contact detection between hand and hand-rim during wheelchair propulsion. The measurement system uses a camera collecting RGB and depth images. The hand is detected through Mediapipe, a software able to recognize the key points of the hand on the RGB image. Hand position is expressed with respect to the wheel. A classifier is used to determine if there is contact between hand and hand-rim. To validate this procedure, 17 able-bodied participants pushed the wheelchair on an ergometer during six tests, given by the combinations of holding a tennis racket in their right hand while propelling at three different speeds: 4 km/h, 5.4 km/h and maximal sprint. Since validated contact detection methods are lacking in literature, experts provided a reference by manually evaluating video recordings and force signals frame-by-frame. The results showed that the hand identification by Mediapipe is not influenced by the presence of the racket but by the speed. Contact events were detected in the 99.5% of the cases. The mean error in contact time detection was -5 ms for the starts and 18 ms for the ends, the standard deviation was 48 ms for both and the combined root mean square error (RMSE) was 48 ms for the starts and 50 ms for the ends. These values, once corrected the systematic effects, lead to a standard uncertainty of approximately 0.05 s, corresponding to 15 % of the average contact duration. The study highlights the potential use of marker-less vision systems for contact detection in wheelchair propulsion.

31 July 2026 in medRxiv
Verified
Preprint
Open access
PDF file
SSSabine Schootemeijer
Sabine Schootemeijer
SKSophie H. Kroesen
Sophie H. Kroesen
NSNiels A. Stens
Niels A. Stens
MNMilou Netten
Milou Netten
ISInge P. Salzmann
Inge P. Salzmann
TCThe Step Coach Collaborators
The Step Coach Collaborators
Background and Aims: Steps are increasingly used to prescribe physical activity, but their impact on quality of life (QoL) remains unclear. We examined the dose-response association between step metrics and QoL, and whether cardiovascular disease (CVD) status moderates this association. Methods: Individual-level data of five studies were pooled. Physical activity was measured with thigh-worn accelerometry. We assessed steps/day, daily minutes of fast stepping (≥100 steps/min), peak 1- and 30- min cadence. We investigated the association of step metrics and QoL (questionnaire-based; standardized) with multivariable (non-)linear regression, and the interaction with CVD status. Results: We included 9,371 participants (62 [54-68] years; 47% female), comprising 1,977 individuals with and 7,394 without CVD. Significant, curvilinear dose-response associations between step metrics and QoL were found. The optimal step volume was 6,561 steps/day which associated with a 0.35 SD (95%CI: 0.28-0.42) higher QoL compared to the referent 4,000 steps/day. The optimal doses for peak 1-min and peak 30-min cadence were 107 steps/minute (+0.34 SD; 95%CI: 0.28-0.41) and 74 steps/minute (+0.29 SD; 95%CI: 0.24-0.34) respectively, compared to references of 90 and 60 steps/minute. Only fast stepping interacted with CVD status, with a lower optimum in those with versus without CVD (4 minutes/day, +0.20 SD, 95%CI: 0.12-0.28 versus 9 minutes/day, +0.19 SD, 95%CI: 0.12-0.25), compared to the referent 2 minutes/day. Conclusions: Step metrics were curvilinearly associated with QoL with optimal benefits at ∼6,500 steps/day. Optimal QoL benefits can be reached at feasible stepping targets, and at slightly fewer daily minutes of fast stepping in CVD versus non-CVD. Structured graphical Key Questions: Is there a dose-response association between step metrics and health-related quality of life (QoL)? Does the cardiovascular disease (CVD) health status moderate this association? Key Findings: More steps/day and time spent at fast stepping are associated with better QoL following a curvilinear dose-response curve. The optimal step volume is 6,561 steps/day, which was independent of CVD status. Individuals with CVD may gain optimal QoL levels at slightly less time of fast stepping (4 min/day) than those without CVD (9 min/day). Take Home Message: More steps and steps at a higher intensity are associated with better QoL. Optimal QoL benefits could be gained at feasible stepping targets (i.e. 4 min/day of fast stepping for CVD, 9 min/day for those without CVD).